Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

People on the Move: Service Companies

Walter H. Moos, Ph.D., was appointed CEO of ShangPharma Innovation.

Read More »

Intouch Solutions Promotes Two to VPs, Client Services

Intouch Solutions proudly announces the promotions of both Vicky Cory and Krisha Newham to vice president of client services.

Read More »

Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees

Nearly nine months after slashing 25 percent of the company’s workforce, Iroko Pharmaceuticals is terminating more than 100 full-time and part-time employees.

Read More »

Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data

A little more than two weeks after being placed on administrative leave, Gur Roshwalb – chief executive officer of Akari Therapeutics – resigned his position.

Read More »

Novartis to Lay Off 250 Nationwide, With 204 from New Jersey U.S. Headquarters

Novartis AG, headquartered in Basel, Switzerland, filed with the state of New Jersey that it plans to lay off more than 200 workers. The company, whose U.S. headquarters are in East Hanover, NJ, is undergoing operational changes.

Read More »

Novartis to Shed Another 500 Jobs, Add 350 High-Tech Jobs

Novartis AG is shaking up its operations by terminating approximately 500 production and development positions in Switzerland, but adding an additional 350 jobs to its growing biotech business, Matthias Leuenberger said in a posting on the company’s Swiss site.

Read More »

Kieran Walsh Appointed President of Greater Than One Inc.

Greater Than One Inc. (GTO) announced the appointment of Kieran Walsh as President of its US operations. Walsh is responsible for leading the GTO staff and offices in New York and San Francisco, and for providing oversight on all US-based accounts.

Read More »

FCB Health Adds Kim Barke as Group Creative Director to Lead Oncology Accounts

NYC-based FCB Health appointed Kim Barke to the role of group creative director to lead its oncology accounts.

Read More »

Teva Cuts Another 500 Jobs, May Hire CEO Who Isn’t Israeli

As Teva Pharmaceutical narrows down its candidate for a new chief executive officer, the company is shuttering a plant in Hungary and laying off 500 employees, according to reports.

Read More »

Novelion CEO quits Novo Nordisk board due to NASH conflict

Danish drugmaker Novo Nordisk said the chief executive of Canadian biotech company Novelion Therapeutics had left its board with immediate effect due to “a potential conflict of interest.”

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom